EDGEWELL PERSONAL CARE Co: Form 10-Q for the period ended Mar 31, 2022
Filed with the SEC on May 10, 2022 and accepted by EDGAR at May 10, 2022, 13:15 ET.
Management's discussion and analysis
As filed, 39,463 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
(Amounts in millions, except per share data, unaudited)
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited Condensed Consolidated Financial Statements and the accompanying notes included in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K filed with the SEC on November 19, 2021 (the “2021 Annual Report”). The following discussion may contain forward-looking statements that reflect our plans, estimates, and beliefs and involve risks, uncertainties, and assumptions. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to these differences include those discussed within “Forward-Looking Statements” below and in Item 1A. Risk Factors and “Forward-Looking Statements” included within our 2021 Annual Report.
Forward-Looking Statements
This document contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”), as amended. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of Edgewell Personal Care Company (“Edgewell,” “we” or “our Company”) or any of our businesses. Forward-looking statements generally can be identified by the use of words or phrases such as “believe,” “expect,” “expectation,” “anticipate,” “may,” “could,” “intend,” “belief,” “estimate,” “plan,” “target,” “predict,” “likely,” “will,” “should,” “forecast,” “outlook,” or other similar words or phrases. These statements are not based on historical facts, but instead reflect our expectations, estimates, or projections concerning future results or events, including, without limitation, the future earnings and performance of our Company or any of our businesses, and the integration of the Billie, Inc. (“Billie”) acquisition and expected benefits from this transaction, including growth opportunities and cost savings. Many factors outside our control could affect the realization of these estimates. These statements are not guarantees of performance and are inherently subject to known and unknown risks, uncertainties and assumptions that are difficult to predict and could cause our actual results to differ materially from those indicated by those statements. We cannot assure you that any of our expectations, estimates or projections will be achieved. The forward-looking statements included in this report are only made as of the date of this report and we disclaim any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances, except as required by law. You should not place undue reliance on these statements.
In addition, other risks and uncertainties not presently known to us or that we presently consider immaterial could significantly affect the forward-looking statements. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty. Risks and uncertainties include those detailed from time to time in our publicly filed documents, including in Item 1A. Risk Factors of Part I of our 2021 Annual Report.
Non-GAAP Financial Measures
While we report financial results in accordance with GAAP, this discussion also includes non-GAAP measures. These non-GAAP measures are referred to as “adjusted” or “organic” and exclude items such as restructuring costs, acquisition and integration costs, and other non-standard items. Reconciliations of non-GAAP measures are included within this Management’s Discussion and Analysis of Financial Condition and Results of Operations.
This non-GAAP information is provided as a supplement to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. We use this non-GAAP information internally to make operating decisions and believe it is helpful to investors because it allows more meaningful period-to-period comparisons of ongoing operating results. Given certain significant events, including the acquisition of Billie, we view the use of non-GAAP measures that take into account the impact of these unique events as particularly valuable in understanding our underlying operational results and providing insights into future performance. The information can also be used to perform trend analysis and to better identify operating trends that may otherwise be masked or distorted by the types of items that are excluded. This non-GAAP information is also a component in determining management’s incentive compensation. Finally, we believe this information provides more transparency.
The following provides additional detail on our non-GAAP measures:
- We analyze net sales and segment profit on an organic basis to better measure the comparability of results between periods. Organic net sales and organic segment profit exclude the impact of changes in foreign currency and the impact of the Billie acquisition.
- Organic net sales will be unfavorably impacted in fiscal 2022 by the Billie acquisition as sales that were previously reported as third party sales to Billie are now included as inter-company sales.
- Segment profit will be unfavorably impacted in fiscal 2022 as a result of a change in the timing of profit recognition due to the Billie acquisition. Subsequent to the acquisition of Billie, profit previously earned on sales to Billie will be deferred until Billie sells to a third party.
- Additionally, we utilize “adjusted” non-GAAP measures including gross profit, SG&A, operating income, income taxes, net earnings, and diluted earnings per share internally to make operating decisions. The following items are excluded when analyzing non-GAAP measures: restructuring and related costs, acquisition and integration costs and other non-standard items.
All comparisons are with the same period in the prior year, unless otherwise noted.
Industry and Market Data
Unless we indicate otherwise, we base the information contained or incorporated by reference herein, concerning our industry on our general knowledge and expectations. Our market position, market share, and industry market size are estimates based on internal and external data from various industry analyses, our internal research and adjustments, and assumptions that we believe to be reasonable. We have not independently verified data from industry analyses and cannot guarantee its accuracy or completeness. In addition, we believe that industry, market size, market position and market share data within our industry provides general guidance but is inherently imprecise and has not been verified by any independent source. Further, our estimates and assumptions involve risks and uncertainties and are subject to change based on various factors, including those discussed in Item 1A. Risk Factors in Part I of our 2021 Annual Report. These and other factors could cause results to differ materially from those expressed in the estimates and assumptions. You are cautioned not to place undue reliance on this data.
Retail sales for purposes of market size, market position and market share information are based on retail sales in U.S. dollars.
Trademarks and Trade Names
We own or have rights to use trademarks and trade names that we use in conjunction with the operation of our business, which appear throughout this Quarterly Report on Form 10-Q. We may also refer to brand names, trademarks, service marks and trade names of other companies and organizations, which are the property of their respective owners.
Impact of COVID-19 Pandemic
Throughout the novel coronavirus 2019 (“COVID-19”) pandemic, we have taken and continue to take significant measures to protect our employees and businesses, while remaining in compliance with local and national guidelines.
The Company’s top priority during this time continues to be ensuring the health and welfare of our employees and additional health and safety measures have been put in place at all of our manufacturing locations. To date, we have not experienced a material operational disruption across our manufacturing or distribution facilities.
The prolonged COVID-19 pandemic environment has resulted in increased supply chain challenges across labor management, product procurement and distribution. The continued duration and severity of COVID-19 pandemic may cause further disruptions related to our key suppliers, increase procurement and distribution costs and impact our ability to hire and retain employees, which may result in higher labor costs going forward. However, the impact, timing and severity of potential disruptions cannot be reasonably estimated at this time.
We expect to maintain adequate liquidity, and we will continue to assess the impact that the COVID-19 pandemic has on our liquidity needs and current economic market conditions. As noted within “Liquidity and Capital Resources” below, the COVID-19 pandemic has not had a significant impact on our liquidity, cash flows or capital resources.
Significant Events
Acquisitions
On November 29, 2021, the Company completed the acquisition of Billie, a leading U.S. based consumer brand company that offers a broad portfolio of personal care products for women, for a purchase price of $309.4, net of cash acquired. We purchased Billie utilizing a combination of cash on hand and drawing on our U.S. revolving credit facility due 2025 (“Revolving Credit Facility”). As a result, Billie became a wholly owned subsidiary of the Company. Refer to Note 2 of Notes to Condensed Consolidated Financial Statements for further discussion.
Executive Summary
The following is a summary of key results for the second quarter and first six months of fiscal 2022 compared to the prior year period. Net earnings and earnings per share (“EPS”) for the periods presented were impacted by restructuring and related costs, acquisition and integration costs, and other non-standard items, as described in the table below. The impact of these items on reported net earnings and EPS are provided as a reconciliation of net earnings and EPS to adjusted net earnings and adjusted diluted EPS, both of which are non-GAAP measures.
Second Quarter of Fiscal 2022
- Net sales in the second quarter of fiscal 2022 increased 5.5% to $547.7. Organic net sales increased 2.1% compared to the prior year quarter due to strong Sun Care, Grooming and Women’s shave performance across both North American and International markets, partially offset by the impact of supply constraints on Feminine Care and certain Wet Shave brands and lower consumption in Wet Ones.
- Net earnings in the second quarter of fiscal 2022 were $23.2 compared to $14.4 in the prior year quarter. On an adjusted basis, net earnings for the second quarter of fiscal 2022 were $27.0 compared to $38.5 in the prior year quarter. Adjusted earnings declined compared to the prior year quarter as lower margins from inflationary pressures including higher materials, labor, and warehousing and distribution costs and higher advertising and promotional expense (“A&P”) were partially offset by higher net sales.
- Net earnings per diluted share during the second quarter of fiscal 2022 were $0.43 compared to $0.26 in the prior year quarter. On an adjusted basis, net earnings per diluted share during the second quarter of fiscal 2022 was $0.50 compared to $0.70 in the prior year quarter.
| Three Months Ended March 31, 2022 Gross Profit | SG&A | Operating Income | EBIT(1) Income taxes | Net Earnings | Diluted EPS | |
|---|---|---|---|---|---|---|
| GAAP — Reported | $230.1 | $101.3 | $41.7 | $27.1 $3.9 | $23.2 | $0.43 |
| Restructuring and related costs | — | 0.2 | 3.7 | 3.7 1.0 | 2.7 | 0.05 |
| Acquisition and integration costs | 0.5 | 0.6 | 1.1 | 1.1 0.2 | 0.9 | 0.02 |
| Sun Care reformulation costs | 0.2 | — | 0.2 | 0.2 — | 0.2 | — |
| Total Adjusted Non-GAAP | $230.8 | $100.5 | $46.7 | $32.1 $5.1 | $27.0 | $0.50 |
| GAAP as a percent of net sales | 42.0% | 18.5% | 7.6% | GAAP effective tax rate | 14.4% | |
| Adjusted as a percent of net sales | 42.1% | 18.3% | 8.5% | Adjusted effective tax rate | 16.0% |
| Three Months Ended March 31, 2021 Gross Profit | SG&A | Operating Income | EBIT(1) Income taxes | Net Earnings | Diluted EPS | |
|---|---|---|---|---|---|---|
| GAAP — Reported | $241.7 | $93.4 | $62.9 | $19.5 $5.1 | $14.4 | $0.26 |
| Restructuring and related costs | — | 2.8 | 5.5 | 5.5 1.3 | 4.2 | 0.08 |
| Acquisition and integration costs | — | 0.3 | 0.3 | 0.3 0.1 | 0.2 | — |
| Cost of early debt retirement | — | — | — | 26.1 6.4 | 19.7 | 0.36 |
| Total Adjusted Non-GAAP | $241.7 | $90.3 | $68.7 | $51.4 $12.9 | $38.5 | $0.70 |
| GAAP as a percent of net sales | 46.6% | 18.0% | 12.1% | GAAP effective tax rate | 26.6% | |
| Adjusted as a percent of net sales | 46.6% | 17.4% | 13.2% | Adjusted effective tax rate | 25.3% |
(1) EBIT is defined as Earnings before Income taxes.
First Six Months of Fiscal 2022
- Net sales for the first six months of fiscal 2022 increased 4.2% to $1,011.0. Organic net sales increased 2.3% compared to the prior year period, due to growth in Sun Care in globally, growth in Wet Shave in International markets and growth in Grooming in North America were offset, in part, by declines in Skin Care and Feminine Care.
- Net earnings for the first six months of fiscal 2022 were $34.4 compared to $32.1 in the prior year. On an adjusted basis, net earnings for the second quarter of fiscal 2022 were $50.2 compared to $61.8 in the prior year period. Adjusted earnings were down due to higher cost of goods sold from inflationary pressures, higher A&P and Selling, General and Administrative (“SG&A”) expense, largely related to amortization costs associated with the Billie acquisition.
- Net earnings per diluted share during the first six months of fiscal 2022 were $0.63 compared to $0.58 in the prior year period. On an adjusted basis, as illustrated in the following table, net earnings per diluted share during the first six months of fiscal 2021 were $0.92 compared to $1.13 in the prior year quarter.
| Six Months Ended March 31, 2022 Gross Profit | SG&A | Operating Income | EBIT Income taxes | Net Earnings | Diluted EPS | |
|---|---|---|---|---|---|---|
| GAAP — Reported | $420.0 | $198.2 | $73.5 | $43.3 $8.9 | $34.4 | $0.63 |
| Restructuring and related costs | — | 0.2 | 5.9 | 5.9 1.6 | 4.3 | 0.08 |
| Acquisition and integration costs | 0.8 | 6.3 | 7.1 | 7.1 0.5 | 6.6 | 0.12 |
| Value-added tax settlement costs | — | 3.4 | 3.4 | 3.4 1.1 | 2.3 | 0.04 |
| Sun Care reformulation costs | 3.5 | — | 3.5 | 3.5 0.9 | 2.6 | 0.05 |
| Total Adjusted Non-GAAP | $424.3 | $188.3 | $93.4 | $63.2 $13.0 | $50.2 | $0.92 |
| GAAP as a percent of net sales | 41.5% | 19.6% | 7.3% | GAAP effective tax rate | 20.5% | |
| Adjusted as a percent of net sales | 42.0% | 18.6% | 9.2% | Adjusted effective tax rate | 20.5% |
| Six Months Ended March 31, 2021 Gross Profit | SG&A | Operating Income | EBIT Income taxes | Net Earnings | Diluted EPS | |
|---|---|---|---|---|---|---|
| GAAP — Reported | $435.0 | $186.5 | $104.5 | $44.7 $12.6 | $32.1 | $0.58 |
| Restructuring and related costs | 0.1 | 3.4 | 9.9 | 9.9 2.5 | 7.4 | 0.14 |
| Acquisition and integration costs | 1.3 | 2.0 | 3.3 | 3.3 0.7 | 2.6 | 0.05 |
| Cost of early retirement of long-term debt | — | — | — | 26.1 6.4 | 19.7 | 0.36 |
| Total Adjusted Non-GAAP | $436.4 | $181.1 | $117.7 | $84.0 $22.2 | $61.8 | $1.13 |
| GAAP as a percent of net sales | 44.8% | 19.2% | 10.8% | GAAP effective tax rate | 28.4% | |
| Adjusted as a percent of net sales | 45.0% | 18.7% | 12.1% | Adjusted effective tax rate | 26.5% |
Operating Results
The following table presents changes in net sales for the second quarter and first six months of fiscal 2022, as compared to the corresponding period in fiscal 2021, and provides a reconciliation of organic net sales to reported amounts.
Net Sales
| Net Sales - Total Company Period Ended March 31, 2022 | Q2 | % Chg | Six Months | % Chg |
|---|---|---|---|---|
| Net sales - fiscal 2021 | $519.3 | $970.4 | ||
| Organic | 11.1 | 2.1% | 22.4 | 2.3% |
| Impact of Billie acquisition, net | 27.4 | 5.3% | 34.2 | 3.5% |
| Impact of currency | (10.1) | (1.9)% | (16.0) | (1.6)% |
| Net sales - fiscal 2022 | $547.7 | 5.5% | $1,011.0 | 4.2% |
For the second quarter of fiscal 2022, net sales were $547.7, an increase of 5.5%, including a $27.4 or 5.3% impact from the acquisition of Billie and a $10.1 or 1.9% unfavorable impact from currency movements. Organic net sales increased 2.1%, reflecting strong Sun Care, Grooming and Women’s shave performance across both North American and International markets, partially offset by the impact of supply constraints on Feminine Care and certain Wet Shave brands, and lower consumption in Wet Ones.
For the first six months of fiscal 2022, net sales were $1,011.0, an increase of 4.2%, including a $34.2 or 3.5% impact from the acquisition of Billie and a $16.0 or 1.6% unfavorable impact from currency movements. Organic net sales increased 2.3% driven by increased volumes in Sun Care and Grooming and favorable pricing for Feminine Care. The increases were offset by declines in volumes in Skin Care and Feminine Care.
For further discussion regarding net sales, including a summary of reported versus organic changes, see “Segment Results.”
Gross Profit
Gross profit was $230.1 during the second quarter of fiscal 2022, compared to $241.7 in the prior year quarter. Gross margin as a percent of net sales for the second quarter of fiscal 2022 was 42.0%. Adjusted gross margin percentage was 42.1%, a decline of 450-basis points compared to the prior year quarter, as 110-basis points of favorable pricing and 200-basis points of productivity gains were more than offset by a 560-basis point impact from commodity inflation and increased transportation and air-freight costs, a 140-basis point impact related to negative mix and higher non-trade spend, and a 60-basis point impact from Billie and unfavorable foreign exchange.
Gross profit was $420.0 during the first six months of fiscal 2022, compared to $435.0 in the prior year period. Gross margin as a percent of net sales for the first six months of fiscal 2022 was 41.5%. Adjusted gross margin percentage was 42.0%, down 300-basis points from the prior year period, driven by commodity inflation, higher warehousing and distribution expenses, and unfavorable product mix, which were partially offset by favorable pricing.
Selling, General and Administrative Expense
SG&A was $101.3 in the second quarter of fiscal 2022, or 18.5% of net sales, compared to $93.4 in the prior year quarter, or 18.0% of net sales. Adjusted SG&A as a percent of net sales was 18.3%, an increase of 90-basis points, driven by higher compensation expense and the additional costs associated with Billie, including increased amortization expense.
SG&A was $198.2 in the first six months of fiscal 2022, or 19.6% of net sales, compared to $186.5 in the prior year period, or 19.2% of net sales. Adjusted SG&A as a percent of net sales was 18.6%, a decline of 10-basis points, driven by lower broker and program expenses and leverage related to higher total net sales. The decline was offset by additional costs incurred associated with Billie, including amortization expense.
Advertising and Sales Promotion Expense
For the second quarter of fiscal 2022, A&P was $69.9, up $1.5 compared to the prior year quarter of $68.4. A&P as a percent of net sales was 12.8%, as compared to 13.2% in the prior year period. The increases in A&P expense were primarily driven by increases in support of sun season execution, the Schick Masterbrand launch and continued investments behind commercial activation in Japan and the U.K.
For the first six months of fiscal 2022, A&P was $116.1, up $6.5 compared to the prior year period. A&P as a percent of net sales was 11.5%, up from 11.3% in the prior year period. The increases in A&P expense were primarily driven by increases in support of Sun Care after COVID-19 pandemic declines in the prior year and higher investment in Wet Shave.
Research and Development Expense
Research and development expense (“R&D”) for the second quarter of fiscal 2022 was $13.7, compared to $14.3 in the prior year quarter. As a percent of net sales, R&D was 2.5% in the second quarter of fiscal 2022 compared to 2.8% in the prior year quarter. R&D for the first six months of fiscal 2022 was $26.5, compared to $28.0 in the prior year period. As a percent of net sales, R&D was 2.6% in the first six months of fiscal 2021, compared to 2.9% in the prior year period. R&D expense was down compared to the prior year driven primarily by timing of program spend for the first half of fiscal 2022.
Interest Expense Associated with Debt
Interest expense associated with debt for the second quarter of fiscal 2022 was $18.0, compared to $17.3 in the prior year quarter. For the first six months of fiscal 2022, interest expense was $35.3 compared to $34.7 in the prior year period. The increase in interest expense was the result of higher overall debt balance from the draw on the Revolving Credit Facility in the first quarter of fiscal 2022 primarily to finance the acquisition of Billie.
Other Income, net
Other income, net was $3.4 in the second quarter of fiscal 2022. There was no other income in the prior year quarter. Other income, net was $5.1 during the first six months of fiscal 2022, compared to $1.0 during the first six months of fiscal 2021. The increase in income was driven by favorable hedge settlements compared to the prior year.
Income Tax Provision
The effective tax rate for the three and six months ended March 31, 2022 was 14.4% and 20.5%, respectively, compared to 26.6% and 28.4% in the prior year period, respectively. On an adjusted basis, the effective tax rate was 16.0% and 20.5% for the three and six months ended March 31, 2022, respectively, and 25.3% and 26.5% for the three and six months ended March 31, 2021, respectively. The fiscal 2022 effective tax rate and adjusted effective tax rate reflect a favorable mix of earnings in low tax jurisdictions and a favorable impact of a change in our prior estimates.
Operating Model Redesign
In fiscal 2022, we expect to take specific actions to strengthen our operating model, simplify our organization and improve manufacturing and supply chain efficiency and productivity. As a result of these actions, we expect to incur one-time charges of approximately $15 in fiscal 2022. We incurred $3.7 and $5.9 during the second quarter and first six months of fiscal 2022, respectively, primarily related to employee severance and benefit costs.
Segment Results
The following tables present changes in segment net sales and segment profit for the second quarter and first six months of fiscal 2022, compared to the corresponding periods in fiscal 2021, and provide a reconciliation of organic segment net sales and organic segment profit to reported amounts. For a reconciliation of segment profit to Earnings before income taxes, refer to Note 15 of Notes to Condensed Consolidated Financial Statements.
Our operating model includes some shared business functions across segments, including product warehousing and distribution, transaction processing functions and, in most cases, a combined sales force and management teams. We apply a fully allocated cost basis in which shared business functions are allocated between segments.
Net sales and segment profit activity related to Billie products were included in the Wet Shave segment for the post-acquisition period.
Wet Shave
| Net Sales - Wet Shave Period Ended March 31, 2022 | Q2 | % Chg | Six Months | % Chg |
|---|---|---|---|---|
| Net sales - fiscal 2021 | $292.7 | $571.8 | ||
| Organic | (6.1) | (2.1)% | (0.1) | —% |
| Impact of Billie acquisition, net | 27.4 | 9.4% | 34.2 | 6.0% |
| Impact of currency | (9.0) | (3.1)% | (14.8) | (2.6)% |
| Net sales - fiscal 2022 | $305.0 | 4.2% | $591.1 | 3.4% |
Wet Shave net sales for the second quarter of fiscal 2022 increased 4.2% compared to the prior year quarter, inclusive of a 9.4% increase from the acquisition of Billie and a 3.1% decline due to currency movements. Organic net sales decreased $6.1, or 2.1%, driven by declines in Men’s systems primarily from lower volumes and unfavorable trade promotional spend in North America, which was partially offset by growth in Women’s systems in North America and International. Organic Net Sales in
North America were impacted by supply constraints which resulted in out-of-stocks for certain Women’s Systems and Men’s and Women’s Shave Preps.
Wet Shave net sales for the first six months of fiscal 2022 increased 3.4%, inclusive of a 6.0% increase from the acquisition of Billie and a 2.6% decline due to currency movements. Organic net sales were relatively flat compared to the prior year and were impacted by favorable pricing and volumes in Latin America, offset by unfavorable volumes due to supply chain constraints in North America. Geographically, International markets increased 2.6%, partially offset by declines in North America totaling 3.2%. There were increased volumes in Women’s Systems and Disposables, compared to declines in Men’s Systems and Shave preps.
| Segment Profit - Wet Shave Period Ended March 31, 2022 | Q2 | % Chg | Six Months | % Chg |
|---|---|---|---|---|
| Segment profit - fiscal 2021 | $45.9 | $98.5 | ||
| Organic | (10.9) | (23.7)% | (7.7) | (7.8)% |
| Impact of Billie acquisition, net | (5.2) | (11.3)% | (7.6) | (7.7)% |
| Impact of currency | (2.2) | (4.9)% | (4.1) | (4.2)% |
| Segment profit - fiscal 2022 | $27.6 | (39.9)% | $79.1 | (19.7)% |
Wet Shave segment profit for the second quarter of fiscal 2022 was $27.6, down $18.3, or 39.9%. Organic segment profit decreased $10.9, or 23.7%, as commodity inflation and increased transportation and air-freight costs were partially offset by favorable pricing across all markets.
Wet Shave segment profit for the first six months of fiscal 2022 was $79.1, down $19.4, or 19.7%. Organic segment profit decreased $7.7, or 7.8%, primarily due to inflationary pressures resulting in higher commodity costs and warehousing and distribution costs, partially offset by favorable pricing and lower A&P expense. Segment profit was negatively impacted $7.6 as a result of the Billie acquisition.
Sun and Skin Care
| Net Sales - Sun and Skin Care Period Ended March 31, 2022 | Q2 | % Chg | Six Months | % Chg |
|---|---|---|---|---|
| Net sales - fiscal 2021 | $159.5 | $262.5 | ||
| Organic | 24.8 | 15.5% | 26.8 | 10.2% |
| Impact of currency | (1.0) | (0.6)% | (1.2) | (0.4)% |
| Net sales - fiscal 2022 | $183.3 | 14.9% | $288.1 | 9.8% |
Sun and Skin Care net sales for the second quarter of fiscal 2022 increased 14.9%. Organic net sales increased $24.8, or 15.5%. The increase in organic net sales was primarily driven by Sun Care growth of more than 28%, reflecting distribution and market share gains in North America and continued category recovery in certain International markets. Additionally, Grooming grew 5.7%, primarily in North America. Wet Ones organic net sales declined 24.5%, reflecting the impact of cycling prior year quarter COVID-19 pandemic related heightened demand.
Sun and Skin Care net sales for the first six months of fiscal 2022 increased 9.8%. Organic net sales increased $26.8, or 10.2%. Organic net sales increases were driven by higher Sun Care volumes, resulting in growth of 31% globally, partially offset by unfavorable trade and coupons. Men’s Grooming increased 6% driven by Cremo and Jack Black. Wet Ones declined 34% driven by lower volumes as demand fell closer to pre-COVID-19 pandemic levels.
| Segment Profit - Sun and Skin Care Period Ended March 31, 2022 | Q2 | % Chg | Six Months | % Chg |
|---|---|---|---|---|
| Segment profit - fiscal 2021 | $36.2 | $41.4 | ||
| Organic | 6.0 | 16.6% | 4.7 | 11.4% |
| Impact of currency | 0.1 | 0.3% | (0.1) | (0.3)% |
| Segment profit -fiscal 2022 | $42.3 | 16.9% | $46.0 | 11.1% |
28
Segment profit for the second quarter of fiscal 2022 was $42.3, an increase of $6.1. Organic segment profit increased $6.0, as higher sales in Sun Care were partially offset by inflationary cost pressures, higher A&P spend and sales declines in Wet Ones.
Segment profit for the first six months of fiscal 2022 was $46.0, an increase of $4.6, or 11.1%. Organic segment profit increased $4.7, or 11.4%, driven primarily by higher sales volumes, partially offset by higher A&P expense.
Feminine Care
| Net Sales - Feminine Care Period Ended March 31, 2022 | Q2 | % Chg | Six Months | % Chg |
|---|---|---|---|---|
| Net sales - fiscal 2021 | $67.1 | $136.1 | ||
| Organic | (7.6) | (11.4)% | (4.3) | (3.2)% |
| Impact of currency | (0.1) | (0.1)% | — | —% |
| Net sales - fiscal 2022 | $59.4 | (11.5)% | $131.8 | (3.2)% |
Feminine Care net sales for the second quarter of fiscal 2022 decreased $7.7, or 11.5%. The decline in net sales reflected the impact of supply constraints due to manufacturing labor shortages and certain ingredient shortages. Consumption increased driven by higher pricing, while market share increased slightly in the quarter.
Feminine Care net sales for the first six months of fiscal 2022 decreased $4.3, or 3.2%. Net sales declines were driven by lower volumes, partially offset by favorable pricing.
| Segment Profit - Feminine Care Period Ended March 31, 2022 | Q2 | %Chg | Six Months | %Chg |
|---|---|---|---|---|
| Segment profit -fiscal 2021 | $5.6 | $14.4 | ||
| Organic | (3.7) | (66.1)% | (4.2) | (29.2)% |
| Impact of currency | — | —% | 0.1 | 0.7% |
| Segment profit - fiscal 2022 | $1.9 | (66.1)% | $10.3 | (28.5)% |
Feminine Care segment profit for the second quarter of fiscal 2022 was $1.9, a decrease of $3.7, or 66.1%, driven by the aforementioned supply chain constraints and increased transportation costs.
Feminine Care segment profit for the first six months of fiscal 2022 was $10.3 a decrease of $4.1, or 28.5%, primarily due to unfavorable gross margin from lower sales volumes and unfavorable cost mix due to inflationary pressures on materials, partially offset by favorable pricing.
General Corporate and Other Expenses
| Quarter Ended March 31, 2022 | 2021 | Six Months Ended March 31, 2022 | 2021 | |
|---|---|---|---|---|
| Corporate expenses | $17.2 | $13.4 | $28.0 | $25.5 |
| Restructuring and related costs | 3.7 | 5.5 | 5.9 | 9.9 |
| Acquisition and integration costs | 1.1 | 0.3 | 7.1 | 3.3 |
| Value-added tax settlement costs | — | — | 3.4 | — |
| Sun Care reformulation costs | 0.2 | — | 3.5 | — |
| Cost of early retirement of long-term debt | — | 26.1 | — | 26.1 |
| General corporate and other expenses | $22.2 | $45.3 | $47.9 | $64.8 |
| % of net sales | 4.1% | 8.7% | 4.7% | 6.7% |
For the second quarter of fiscal 2022, corporate expenses were $17.2, or 3.1% of net sales, compared to $13.4, or 2.6% of net sales. For the first six months of fiscal 2022, corporate expenses were $28.0, or 2.8% of net sales, compared to $25.5, or 2.6% of net sales. For the second quarter and six months ended March 31, 2022, the increase in corporate expense was primarily due to higher salary and benefit costs.
Liquidity and Capital Resources
At March 31, 2022, a portion of our cash balances were located outside the U.S. Given our extensive international operations, a significant portion of our cash is denominated in foreign currencies. We manage our worldwide cash requirements by reviewing available funds among the many subsidiaries through which we conduct business and the cost effectiveness with which those funds can be accessed. We generally repatriate a portion of current year earnings from select non-U.S. subsidiaries only if the economic cost of the repatriation is not considered material.
The counterparties that hold our deposits consist of major financial institutions. We consistently monitor positions with, and the credit ratings of, counterparties both internally and by using outside ratings agencies.
Our total borrowings were $1,454.8 at March 31, 2022, including $204.8 tied to variable interest rates. Our total borrowings at September 30, 2021 were $1,276.5. We had outstanding borrowings of $179.0 under the Revolving Credit Facility at March 31, 2022, primarily to fund the acquisition of Billie. Taking into account outstanding letters of credit of $6.3, as of March 31, 2022, $239.7 was available under the Revolving Credit Facility. We had outstanding international borrowings, recorded in Notes payable, of $25.8 and $26.5 as of March 31, 2022 and September 30, 2021, respectively.
Effective February 7, 2022, we increased the maximum receivables sold facility amount under the Sixth Amendment to Master Accounts Receivable Purchase Agreement to $180.0 from $150.0 and amended the pricing index used to determine the purchase price for subject receivables from LIBOR to the Bloomberg Short Term Bank Yield Index (“BSBY”). The applicable margin that is added to the BSBY pricing index specific for each obligor was unchanged. Except as noted above, all other terms, conditions, obligations, covenants or agreements contained in the Accounts Receivable Facility are unmodified in all respects and continue in full force and effect.
Historically, we have generated, and expect to continue to generate, positive cash flows from operations. Our cash flows are affected by the seasonality of our Sun Care products, typically resulting in higher net sales and increased cash generated in the second and third quarter of each fiscal year. While we cannot reasonably estimate the full impact of the COVID-19 pandemic will have on our cash flows, we believe our cash on hand, cash flows from operations and borrowing capacity under our Revolving Credit Facility will be sufficient to satisfy our future working capital requirements, interest payments, R&D activities, capital expenditures, and other financing requirements for at least the next 12 months. We will continue to monitor our cash flows, spending and liquidity needs.
To date, the COVID-19 pandemic has not had a significant impact on our liquidity or capital resources. However, the COVID-19 pandemic has led to disruption and volatility in the global capital markets, which, depending on future developments, could impact our capital resources and liquidity in the future.
Short-term financing needs consist primarily of working capital requirements and principal and interest payments on our long-term debt. Long-term financing needs will depend largely on potential growth opportunities, including acquisition activity and repayment or refinancing of our long-term debt obligations. We may, from time-to-time, seek to repurchase shares of our common stock. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. Our long-term liquidity may be influenced by our ability to borrow additional funds, renegotiate existing debt, and raise equity on terms that are favorable to us.
As of March 31, 2022, we were in compliance with the provisions and covenants associated with our debt agreements.
Cash Flows
A summary of our cash flow activities is provided in the following table:
| Net cash (used by) from: | Six Months Ended March 31, 2022 | 2021 |
|---|---|---|
| Operating activities | $(39.9) | $(18.8) |
| Investing activities | (325.7) | (13.6) |
| Financing activities | 78.3 | (52.1) |
| Effect of exchange rate changes on cash | (3.8) | 1.9 |
| Net decrease in cash and cash equivalents | $(291.1) | $(82.6) |
Operating Activities
Cash flow used by operating activities was $39.9 during the first six months of fiscal 2022, compared to $18.8 used during the prior year period, driven by lower adjusted net earnings.
Investing Activities
Cash flow used by investing activities was $325.7 during the first six months of fiscal 2022, compared to $13.6 used during the prior year period. We completed the acquisition of Billie for $309.4, net of cash acquired, in fiscal 2022. Additionally, we collected $5.0 of proceeds from the sale of the Infant and Pet Care business during the first six months of fiscal 2022, compared to $7.5 in the prior year period. Capital expenditures were $25.0 during the first six months of fiscal 2022, compared to $22.2 in the prior year period.
Financing Activities
Net cash from financing activities was $78.3 during the first six months of fiscal 2022, compared to cash used of $52.1 in the prior year period. During the first six months of fiscal 2022, we had net borrowings of $179.0 under our Revolving Credit Facility, primarily to fund the acquisition of Billie. We repurchased $75.4 of our common stock under our 2018 Board authorization to repurchase our common stock (the “Repurchase Plan”) compared to $9.2 in the prior year period. Dividend payments totaled $16.7 in the first six months of fiscal 2022, compared to $8.4 in the prior year period. We had financing outflows for employee equity awards held for taxes totaling $9.7 in the first six months of fiscal 2022, compared to $3.0 in the prior year period. In fiscal 2021, we replaced our $500 2022 Senior Notes with the issuance of $500 2029 Senior Notes. Additional financing cash outflows incurred were related to costs of early debt retirement of the 2022 Senior Notes totaling $26.5 and debt issuance costs of $5.9.
Share Repurchases
During the first six months of fiscal 2022, we repurchased 1.9 shares of our common stock for $75.4. We have 7.8 shares remaining under the Repurchase Plan. Future share repurchases, if any, would be made in the open market, privately negotiated transactions or otherwise, in such amounts and at such times as we deem appropriate based upon prevailing market conditions, business needs and other factors.
Dividends
On February 4, 2022, the Board declared a quarterly cash dividend of $0.15 per common share for the first fiscal quarter. The dividend was paid April 5, 2022, to stockholders of record as of the close of business on March 8, 2022.
Dividends declared during the six months ended March 31, 2022 totaled $16.6. Payments made for dividends during the six months ended March 31, 2022 totaled $16.7.
On May 6, 2022, the Board declared a quarterly cash dividend of $0.15 per common share for the second fiscal quarter. The dividend is payable July 7, 2022 to stockholders of record as of the close of business on June 2, 2022.
Commitments and Contingencies
Contractual Obligations
At March 31, 2022, we had outstanding borrowings of $179.0 under the Revolving Credit Facility. As of March 31, 2022, future minimum repayments of debt were: $179.0 in fiscal 2025, $750.0 in fiscal 2028 and $500.0 in fiscal 2029.
There have been no other material changes in our contractual obligations since the presentation in our 2021 Annual Report.
Market risk
As filed, 1,232 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The market risk inherent in our financial instruments and positions represents the potential loss arising from adverse changes in currency rates, commodity prices, and interest rates. At times, we enter into contractual arrangements (derivatives) to reduce these exposures. For further information on our foreign currency derivative instruments, refer to Note 14 of Notes to Condensed Consolidated Financial Statements. As of March 31, 2022, there were no open derivative or hedging instruments for future purchases of raw materials or commodities. Our exposure to interest rate risk relates primarily to our variable-rate debt instruments, which currently bear interest based on LIBOR plus margin. As of March 31, 2022, our outstanding variable-rate debt included $204.8 related to our Revolving Credit Facility and international, variable-rate notes payable. Assuming a one-percent increase in the applicable interest rates, annual interest expense on these variable-rate debt instruments would increase approximately $2.0.
There have been no material changes in our assessment of market risk sensitivity since our presentation of Quantitative and Qualitative Disclosures About Market Risk in our 2021 Annual Report on Form 10-K.
Controls and procedures
As filed, 1,145 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Exchange Act, is recorded, processed, summarized and reported within the specified time periods, and that such information is accumulated and communicated to management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate, to allow timely decisions regarding required disclosure.
Our management, with the participation of our CEO and CFO, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of March 31, 2022. Based on that evaluation, our CEO and CFO concluded that, as of that date, our disclosure controls and procedures were effective.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting during the quarter ended March 31, 2022 that have materially affected, or are likely to materially affect, our internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-01-01 to 2022-03-31 | $547.7m | us-gaap:Revenues |
| Revenue | 6 months2021-10-01 to 2022-03-31 | $1.01bn | us-gaap:Revenues |
| Cost of revenue | 3 months2022-01-01 to 2022-03-31 | $317.6m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2021-10-01 to 2022-03-31 | $591.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2022-01-01 to 2022-03-31 | $230.1m | us-gaap:GrossProfit |
| Gross profit | 6 months2021-10-01 to 2022-03-31 | $420.0m | us-gaap:GrossProfit |
| Research and development | 3 months2022-01-01 to 2022-03-31 | $13.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2021-10-01 to 2022-03-31 | $26.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2022-01-01 to 2022-03-31 | $101.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2021-10-01 to 2022-03-31 | $198.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-01-01 to 2022-03-31 | $41.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2021-10-01 to 2022-03-31 | $73.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-01-01 to 2022-03-31 | $18.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2021-10-01 to 2022-03-31 | $35.3m | us-gaap:InterestExpense |
| Income tax | 3 months2022-01-01 to 2022-03-31 | $3.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2021-10-01 to 2022-03-31 | $8.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-01-01 to 2022-03-31 | $23.2m | us-gaap:NetIncomeLoss |
| Net income | 6 months2021-10-01 to 2022-03-31 | $34.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-01-01 to 2022-03-31 | $0.43 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2021-10-01 to 2022-03-31 | $0.63 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-01-01 to 2022-03-31 | $0.43 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2021-10-01 to 2022-03-31 | $0.64 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-01-01 to 2022-03-31 | 54,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2021-10-01 to 2022-03-31 | 54,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2021-10-01 to 2022-03-31 | −$39.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2021-10-01 to 2022-03-31 | $25.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 6 months2021-10-01 to 2022-03-31 | $16.7m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2021-10-01 to 2022-03-31 | $75.4m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2022-03-31 | $968.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-03-31 | $3.79bn | us-gaap:Assets |
| Current liabilities | At period end2022-03-31 | $544.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-03-31 | $2.28bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-03-31 | $1.41bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2022-03-31 | $1.52bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001096752-22-000017. Last ingested by Listed: Nov 14, 2026, 23:53 ET. Listed shows no prices and gives no investment advice.